ada standards of care 2025 glp-1 receptor agonists recommendations in Diabetes Guidelines Must read for all doctors ▪️ Cardiovascular risk: Use RA or SGLT2 inhibitors for glycemic control & cardiovascular risk reduction. ▪️ Heart failure: Standards of Care in Diabetes
Description
A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro
or oral administration
Retatrutide (LY3437943) triple GIP/GLP-1/Glucagon agonist 99% purity
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, according to a new study.
Form: Lyophilized White Powder
